Hosted on MSN12mon
Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapyThe Committee for Medicinal Products for Human Use (CHMP) recommended expansion of the Carvykti label to include adult patients with relapsed and refractory multiple myeloma, who have received at ...
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...
Continued monitoring of absolute lymphocyte count (ALC) during treatment and follow ... used to risk-stratify patients with multiple myeloma. Image: Adobe Stock “The peripheral blood ALC is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results